All articles by Dominic Tyer (European Pharmaceutical Review)
-
ArticleGaelic Labs: Pharma is increasingly focused on supply chain security
General Manager Brian Morrissey discusses his company’s acquisition of fellow Beta-Lactam manufacturer Athlone Laboratories and its implications for an evolving industry.
-
NewsNeuland Laboratories to open Hyderabad commercial peptide facility
The CDMO’s Module 1 commercial production module is expected to be operational by summer 2026.
-
NewsRois appoints Kimberlee Steele as Chief Commercial Officer
She joins the Madrid-headquartered contract development and manufacturing organisation from SHL Medical.
-
NewsRottendorf and Corealis collaborate on OSD manufacturing
The two CDMOs sign an alliance to offer an integrated early-development offering and accelerated commercial pathway.
-
NewsFresenius Kabi and Phlow onshore US epinephrine manufacturing
The collaboration covers the essential medicine's active pharmaceutical ingredients (APIs) and finished doses.
-
NewsVetter Pharma outlines plans for new manufacturing site in Germany
The CDMO is also building a new US aseptic clinical production facility in Illinois as it expands its global footprint.
-
NewsArdena divests Södertälje drug substance site to Nanologica
The CDMO and CRO’s Swedish API facility will now operate as a Nanologica subsidiary, reverting to its original name Syntagon.
-
NewsSever Pharma Solutions appoints Niklas Lindgren as VP of Quality
He joins the Swedish CDMO from medical device company Dignitana.
-
NewsDr Michael J. Miller joins Spore.Bio as VP of Scientific and Regulatory Affairs
The French start-up focuses on advancing rapid microbiology in manufacturing quality control.
-
NewsKincell Bio promotes Bruce Thompson to President and Chief Technology Officer
The cell therapy-focused CDMO has also elevated Melodie Bryce to Chief Quality Officer and Matt Haines to Chief Operations Officer.
-
ArticleReiThera on vaccines and remaining nimble around emerging threats
As vaccines are buffeted by political pressures, the CDMO discussed its growth approach and some of its key collaborations.
-
News
Automation joins AI and cybersecurity as digital priorities for Indian pharma
But the sector’s digital transformation ambitions within their quality functions have only been partially realised.
-
ArticleFujifilm's Lars Petersen on trust-based partnerships and a ‘people first’ culture
Named CEO of the Year at CPHI Frankfurt, the CDMO’s head talks about the type of company he and his team are building.
-
News
Amgen acquires UK cancer biotech Dark Blue Therapeutics for $840m
Gains access to the company’s small molecule-targeted protein degraders to expand its oncology pipeline.
-
News
US oral GLP-1 first as Novo Nordisk launches Wegovy pill
The obesity drug’s new formulation gains an important opportunity to define the market before regulators finish assessing Lilly’s rival orforglipron.
-
NewsSamsung gains first US manufacturing site through $280m GSK deal
The CDMO will acquire the pharma company’s Human Genome Sciences facility in Maryland.
-
NewsGeneric manufacturer safety records revealed by new consumer app
News organisation ProPublica’s Rx Inspector tool connects FDA information on factory location and regulatory records to individual generic drugs.
-
NewsAlnylam invests $250m to boost RNAi manufacturing in the US
Will add its enzymatic ligation platform, now accepted on the FDA’s emerging technology programme, to its Norton, Massachusetts site.
-
NewsChitose and Fujifilm Biosciences sign biopharma manufacturing alliance
The deal will see the companies combine their respective work on CHO-MK cells and GMP-manufactured culture media.
-
NewsGaelic Labs boosts its beta lactam manufacturing with Athlone deal
The move consolidates Ireland’s two leading producers of the antibiotics.